View as an RSS Feed
View The Biggest Lilliputian's Articles BY TICKER:
Myriad Genetics: A Booming Opportunity In Molecular Diagnostics - Part 1
- Myriad Genetics has a strong financial position, despite regulatory and judiciary constraints.
- Molecular diagnostics has been gaining traction for over a decade, and continues its momentum into the present.
- Myriad Genetics has a profitable business with its breast cancer molecular diagnostic tests, proving a successful concept, a successful execution, and a strong market demand.
- The next test to emerge from the pipeline is set to be a blockbuster.